AaronMorrisEtraMD
Hematology • New York, NYClotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Division of Hematology and Medical Oncology
Dr. Etra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2012 - 2015
Albert Einstein College of MedicineClass of 2012- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2015 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Autologous Stem Cell Transplant for Crohn's Disease Start of enrollment: 2017 Jul 12
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group.Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis Ayuk
Transplantation and Cellular Therapy. 2025-01-01 - Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients.Carlos A Ortega Rios, Muna Qayed, Aaron M Etra, Ran Reshef, Richard Newcomb
Transplantation and Cellular Therapy. 2024-11-01 - Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.Joseph A Pidala, Jongphil Kim, Denise Kalos, Corey S Cutler, Zachariah DeFilipp
Blood Advances. 2024-10-25
Press Mentions
Itacitinib Appears Effective for Acute Graft-Versus-Host DiseaseFebruary 12th, 2023- Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow TransplantDecember 13th, 2022
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
